General Internal Medicine

Acute Coronary Syndrome

Questions discussed in this category

Which factors favor extended dual antiplatelet therapy beyond one year in ACS patients with low bleeding risk?

1 Answer available

Papers discussed in this category

J Am Heart Assoc, 2019 Oct 02

Extended Duration of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: How Long Is Too Long?

Circulation, 2022 Nov 07

Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy After Percutaneous Coronary Intervention: The HOST-EXAM Extended Study.

Related Topics in General Internal Medicine